Articles published in Pharmacognosy Communications

Export 86 results:
Author Title Type [ Year(Asc)]
Filters: Author is Ian Edwin Cock  [Clear All Filters]
2019
Mpala L, Chikowe G, Cock IEdwin. Brachychiton rupestris (T.Mitch. ex Lindl.) K. Schum. Extracts Inhibit the Growth of Streptococcus pyogenes. Pharmacognosy Communications. 2019;9(1):27-33.  (833.5 KB)
Chikowe G, Mpala L, Cock IEdwin. Callistemon linearis Schrad. and J.C. Wendl. Extracts Inhibit the Growth of Gram-Positive Bacteria but have no Effect on Gram Negative Bacteria. Pharmacognosy Communications. 2019;9(2):39-46.  (1.03 MB)
Mpala L, Chikowe G, Cock IEdwin. Cordyline rubra Otto and A. Dietr. Leaf and Fruit Extracts Lack Antibacterial Activity and are Non-toxic in vitro. Pharmacognosy Communications. 2019;9(4):130-134.  (929.71 KB)
Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(3):84.  (221.48 KB)
Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(4):123.  (232.81 KB)
Cock IEdwin. Editorial. Pharmacognosy Communications. 2019;9(2):38.  (169.59 KB)
Mazerand C, Cock IEdwin. An Examination of the Antibacterial, Antifungal, Anti-Giardial and Anticancer Properties of Buchanania obovata Engl. Fruit Extracts. Pharmacognosy Communications. 2019;9(1):07-14.  (889.29 KB)
Cock IEdwin. Grevillea juncifolia Hook. and Grevillea robusta A. Cunn. Ex. R. Br. Methanolic Leaf and Flower Extracts Inhibit the Growth of Gram Positive and Gram Negative Bacteria. Pharmacognosy Communications. 2019;9(3):112-117.  (602 KB)
Aldosary H, Wright MHenry, Lee CJay, Greene ACarlson, Cock IEdwin. The Growth Inhibitory Activity of Tasmannia lanceolata (Poir.) A.C. Sm against the Food-poisoning Pathogen Yersinia enterocolitica. Pharmacognosy Communications. 2019;9(4):143-148.  (450.35 KB)
Mpala L, Chikowe G, Cock IEdwin. The Inhibitory Activity of Mischarytera lauteriana (F.M.Bailey) Leaf Extracts against a Panel of Bacterial Pathogens. Pharmacognosy Communications. 2019;9(2):47-53.  (915.09 KB)
Hanna J, Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2019;9(4):149-151.  (976.26 KB)
Cock IEdwin. The Janus Corner. Pharmacognosy Communications. 2019;9(3):118-120.  (295.25 KB)
Cock IEdwin. Medicinal Plant Images. Pharmacognosy Communications. 2019;9(4):152.  (546.69 KB)
Cock IEdwin. Medicinal Plant Images. Pharmacognosy Communications. 2019;9(2):82.  (132.14 KB)
Cock IEdwin. Medicinal Plant Images. Pharmacognosy Communications. 2019;9(3):121.  (464.84 KB)
Chikowe G, Mpala L, Cock IEdwin. Melodorum leichhardtii (F. Muell.) Benth. Extracts Inhibit the Growth of Klebsiella pneumoniae. Pharmacognosy Communications. 2019;9(1):15-20.  (713.67 KB)
Mpala L, Chikowe G, Cock IEdwin. Piper novae-hollandiae Miq. Leaf Extracts Lack Antibacterial activity and are Non-Toxic in vitro. Pharmacognosy Communications. 2019;9(2):75-79.  (991.42 KB)
Lee CJay, Wright MHenry, Greene ACarlson, Aldosary H, Cock IEdwin. Preliminary Evaluations of the Antibacterial Activity of Tasmannia lanceolata against Bacillus anthracis: Natural Resource Probing to Prevent Anthrax. Pharmacognosy Communications. 2019;9(4):124-129.  (462.33 KB)

Pages

Founded:  In 2004, as the PHCOG.NET – a non-profit private organization dedicated to Natural Products Research leading to develop promising drugs. Our main mission is to make information on herbal drug research readily available in different formats to suit the individual needs.

Pharmacognosy Communications [Phcog Commn.] is a new quarterly journal published by Phcog.Net. It is a peer reviewed journal aiming to publish high quality original research articles, methods, techniques and evaluation reports, critical reviews, short communications, commentaries and editorials of all aspects of medicinal plant research. The journal is aimed at a broad readership, publishing articles on all aspects of pharmacognosy, and related fields. The journal aims to increase understanding of pharmacognosy as well as to direct and foster further research through the dissemination of scientific information by the  publication of manuscripts. The submission of original contributions in all areas of pharmacognosy are welcome.

The journal aims to cater the latest outstanding developments in the field of pharmacognosy and natural products and drug design covering but not limited to the following topics:

  • Pharmacognosy and pharmacognistic investigations
  • Research based ethnopharmacological evaluations
  • Biological evaluation of crude extracts, essential oils and pure isolates
  • Natural product discovery and evaluation
  • Mechanistic studies
  • Method and technique development and evaluation
  • Isolation, identification and structural elucidation of natural products
  • Synthesis and transformation studies

Distinctions:  The most widely read, cited, and known Pharmacognosy Communications and website is well browsed with all the articles published. More than 20,000 readers in nearly every country in the world each month

Aim and Scope | Editorial Board | Indexed & Abstracted | Instruction to Authors | Manuscript Submission & Charges

Subjects Covered : Natural Products, Pharmacognosy, Phytochemistry, Marine Pharmacognosy and Zoo Pharmacognosy
ISSN :2249-0159 (Print) ; 2249-0167 (Online) Frequency : Quarterly Rapid at a time publication (4 issues/year)

Indexed and Abstracted in : Chemical Abstracts, Excerpta Medica / EMBASE, Google Scholar, CABI Full Text, Ulrich’s International Periodical Directory, ProQuest, Journalseek & Genamics, PhcogBase, EBSCOHost, Academic Search Complete, Open J-Gate, SciACCESS.
Rapid publication: Average time from submission to first decision is 30 days and from acceptance to In Press online  publication is 45 days.
Open Access Journal: Phcog Commn. is an open access journal, which allows authors to fund their article to be open access from publication.